Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NABI-IGIV 10% in Primary Immune Deficiency Disorders
NCT00538915Phase 3Completed
- Sponsor
- ADMA Biologics, Inc.
- Start
- Sep 2007
- Primary completion
- Jul 2009
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of IgPro10 in primary immunodeficiency (PID), sponsored by ADMA Biologics, Inc.. Started Sep 2007; status: completed.
02
Drugs
IgPro10
03
Conditions
primary immunodeficiency (PID)
Beyond the preview
Go deeper on NCT00538915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538915.